OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases
Luciana Scotti, Teresa Carolliny Moreira Lustoza Rodrigues, Natália Ferreira de Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 5, pp. 349-370
Closed Access | Times Cited: 8
Luciana Scotti, Teresa Carolliny Moreira Lustoza Rodrigues, Natália Ferreira de Sousa, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 5, pp. 349-370
Closed Access | Times Cited: 8
Showing 8 citing articles:
Polypharmacology: promises and new drugs in 2022
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 755-770
Open Access | Times Cited: 27
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 755-770
Open Access | Times Cited: 27
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 12
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 12
Future prospective of AI in drug discovery
Mithun Bhowmick, Sourajyoti Goswami, Pratibha Bhowmick, et al.
Advances in pharmacology (2025)
Closed Access
Mithun Bhowmick, Sourajyoti Goswami, Pratibha Bhowmick, et al.
Advances in pharmacology (2025)
Closed Access
Polypharmacology: new drugs in 2023–2024
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2025)
Open Access
Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker
Pharmacological Reports (2025)
Open Access
Artificial Intelligence in The Management of Neurodegenerative Disorders
Sanchit Dhankhar, Somdutt Mujwar, Nitika Garg, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 931-940
Closed Access | Times Cited: 5
Sanchit Dhankhar, Somdutt Mujwar, Nitika Garg, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 931-940
Closed Access | Times Cited: 5
An in silico investigation: Can melatonin serve as an adjuvant in NR1D1-linked chronotherapy for amyotrophic lateral sclerosis?
Emine Erdag, Ismail Celil Haskologlu, Merve Mercan, et al.
Chronobiology International (2023) Vol. 40, Iss. 10, pp. 1395-1403
Closed Access | Times Cited: 4
Emine Erdag, Ismail Celil Haskologlu, Merve Mercan, et al.
Chronobiology International (2023) Vol. 40, Iss. 10, pp. 1395-1403
Closed Access | Times Cited: 4
Multi-target Phenylpropanoids Against Epilepsy
Teresa Carolliny Moreira Lustoza Rodrigues, Arthur Lins Dias, Aline Matilde Ferreira dos Santos, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 13, pp. 2168-2190
Closed Access
Teresa Carolliny Moreira Lustoza Rodrigues, Arthur Lins Dias, Aline Matilde Ferreira dos Santos, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 13, pp. 2168-2190
Closed Access
Lipidomics-driven drug discovery and delivery strategies in glioblastoma
Xiaohui Weng, Michael Gonzalez, Jeannes Angelia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167637-167637
Open Access
Xiaohui Weng, Michael Gonzalez, Jeannes Angelia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167637-167637
Open Access
